Why Did All Patients with Atrial Fibrillation and High Risk of Stroke Not Receive Oral Anticoagulants? Results of the Polish Atrial Fibrillation (POL-AF) Registry.
Anna SzpotowiczIwona Gorczyca-GłowackaOlga JelonekBeata Uziębło-ŻyczkowskaMałgorzata MaciorowskaMaciej WójcikRobert BłaszczykAgnieszka Kapłon-CieślickaMonika GawalkoMonika BudnikTomasz TokarekRenata Rajtar-SalwaJacek BilMichał WojewódzkiJanusz BednarskiElwira Bakuła-OstalskaAnna Tomaszuk-KazberukAnna SzyszkowskaMarcin WełnickiArtur MamcarzMałgorzata KrzciukBeata Wożakowska-KapłonPublished in: Journal of clinical medicine (2021)
Most AF patients with a high thromboembolic risk received OACs. The factors predisposing a lack of OAC use in these patients were conditions that significantly increased the risk of bleeding complications.